Climbing RAS, the everest of oncogenes

Research output: Contribution to journalArticlepeer-review

Abstract

Mutations that activate the small GTP-binding protein KRAS are the most common oncogenic event in human tumors. Thirty years after its discovery, mutant KRAS has yet to be therapeutically conquered.

Original languageEnglish
Pages (from-to)19-21
Number of pages3
JournalCancer Discovery
Volume4
Issue number1
DOIs
Publication statusPublished - Jan 2014

ASJC Scopus subject areas

  • Oncology

Fingerprint Dive into the research topics of 'Climbing RAS, the everest of oncogenes'. Together they form a unique fingerprint.

Cite this